Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues

Immunopharmacology

Volumn 36, Issue 2-3, 1997, Pages 185-191

  Nolly, Héctor ^a   Miatello, Roberto ^a   Damiani, María Teresa ^a   Abate, Carlos Derlis ^b  

^a Lab Exp Hypertension Vasoactive S   (Argentina)

^b HAYEC   (Argentina)

Author keywords

Aortic banding; Aortocaval shunt; Isolated perfused rat heart; Kallikrein; Kinin; Kininogen

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KALLIKREIN; KININ; KININOGEN; PROTEIN SYNTHESIS INHIBITOR; PUROMYCIN; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WEIGHT; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATED HEART; KALLIKREIN KININ SYSTEM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BRADYKININ; DISEASE MODELS, ANIMAL; HEART; HEART FAILURE, CONGESTIVE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR; KALLIKREIN-KININ SYSTEM; KALLIKREINS; KININOGENS; MALE; MYOCARDIUM; ORGAN SIZE; PROTEIN SYNTHESIS INHIBITORS; PUROMYCIN; RADIOIMMUNOASSAY; RAMIPRIL; RATS; RATS, WISTAR;

EID: 0030872073     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00020-9     Document Type: Conference Paper

References (17)

1. Bhoola, K.D., Figueroa, C.D., Worthy, K., 1992. Bioregulation of kinins, kallikreins, kininogens and kininases. Pharmacol. Rev. 44, 1-80.
2. Clements, J., Mukhtar, A., 1994. Kallikrein gene expression in the heart and kidney: Kallikrein and kinins and cardiovascular functions. Abstracts of the Official satellite to the 15th Scientific Meeting of the International Society of Hypertension, Melbourne, p. 7.
3. Garcia, R., Diebold, S., 1990. Single, rapid and effective method of producing aortocaval shunts in the rat. Cardiovasc. Res. 24, 430-432.
4. Gavras, I., 1992. Bradykinin-mediated effects of ACE inhibitors. Kidney Int. 42, 1020-1029.
5. Linz, W., Martorana, P.A., Schölkens, B.A., 1990. A local inhibition of bradykinin degradation in ischemic hearts. J. Cardiovasc. Pharmacol. 15 (Suppl. 6), S99-S109.
6. Linz, W., Wiemer, G., Schölkens, B.A., 1992. ACE inhibition induces NO-formation in culture bovine endothelial cells and protects isolated ischemic rat hearts. J. Mol. Cell Cardiol. 24, 909-919.
7. Martorana, P.A., Kettenbach, B., Breipohl, G., Linz, W., Schölkens, B.A., 1990. Reduction of infarct size by local angiotensin converting enzyme inhibition is abolished by bradykinin antagonist. Eur. J. Pharmacol. 182, 395-396.
8. Mombouli, J.V., Vanhoutte, P.M., 1995. Kinins and endothelial control of vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 35, 679-705.
9. Nolly, H.L., Scicli, A.G., Scicli, G., Carrtero, O.A., 1985. Characterisation of a kininogenase from rat vascular tissue resembling tissue kallikrein. Circ. Res. 56, 816-821.
10. Nolly, H.L., Carretero, O.A., Scicli, A.G., 1993. Kallikrein release by vascular tissue. Am. J. Physiol. 265, H1209-H1214.
11. Nolly, H.L., Carbini, L., Carretero, O.A., 1994. Scicli AG: A local kallikrein-kinin system is present in rat hearts. Hypertension 23 (2), 919-923.
12. Nolly, H.L., Britos, J., 1981. Kinin-forming enzyme in rat cardiac tissue. Hypertension 3, 42-45.
13. Saed, G.M., Carretero, O.A., MacDonald, R.J., Scicli, A.G., 1990. Kallikrein messenger RNA in rat arteries and veins. Circ. Res. 62, 510-516.
14. Schölkens, B.A., Linz, W., 1992. Bradykinin-mediated metabolic effects in isolated perfused rat hearts. Agent Actions 38 (II), 36-42.
15. Schölkens, B.A., Linz, W., König, W., 1988. Effects of the angiotensin converting enzyme inhibitor ramipril in isolated ischemic rat heart are abolished by a bradykinin antagonist. J. Hypertens. 6 (Suppl. 4), S25-S28.
16. Schölkens, B.A., Linz, W., Martorana, P.A., 1991. Experimental cardiovascular benefits of angiotensin converting enzyme inhibitors: Beyond blood pressure reduction. J. Cardiovasc. Pharmacol. 18 (Suppl. 2), S26-S30.
17. Xiong, W., Chen, L.M., Woodley-Miller, C., Simson, J.A., Chao, J., 1990. Identification and localization of tissue kallikrein in the heart. Biochem. J. 267, 639-646.